🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fantastic EASL meeting in Florence on biliary fibrosis. Expert melding of pre-clinical and clinical topics. New important targets and mechanisms discussed. Thanks to Drs. Pinzani and Strazzabosco for organizing.

One week for the fantastic Metabolic Health focused SouthEast Pediatric Research Conference at the GA Aquarium. Looking forward to seeing all of you who will be able to join us.

Getting the day started with our #pedsresearch2023 Conference Co-Chairs, Drs. Jaydev Desai, Erica Johnson, and Saul Karpen! You can view the full program for the day using the QR code on your badge or by clicking here: bit.ly/3WQj2uS

New paper in Bio-Protocol! LiverQuant is a new method for researchers interested in quantifying fibrosis, macrophages, or cholangiocytes in whole-slide images! A highlight of its main features:

Very interesting and intriguing analysis identifying elevated unconjugated serum bile acids in those who respond to IBAT inhibition with ABCB11 (BSEP) deficiencies. We need such deep-dive research, directly studying BA flux and microbial metabolism. gastrojournal.org/article/S0016-…

Award for his 30 years of academic career! Marco Arrese, MD you are a role model for all of us. Facultad Medicina UC UC Chile -Pontificia Universidad Católica de Chile Asociación Chilena de Hepatología ALEH AASLD EASLnews Luis Antonio Díaz, MD Dr. Alejandro Soza  Francisco Idalsoaga MD

1st author review - written with my PI Saul Karpen - we discuss the genetic determinants that alter regulation of cholangiocyte development → inducing biliary atresia pathogenesis 🧬 A new framework for understanding BA etiology: thieme-connect.com/products/ejour…

Many thanks again to the ⁦Los Angeles Times⁩ for rolling the dice with me on this opinion piece and standing up for science. Not long ago we took this for granted, but tragically for the nation this is no longer the case.

.VCU names pediatric hepatologist @SaulKarpen as the liver institute's first Chief Scientific Officer. Karpen, from Emory University, will lead the expansion of research on the liver and metabolic diseases at the institute. bit.ly/3N9s5U8 #livertwitter AASLD

Honored and delighted to be joining the superb team at the SSLI. Together, we will be working to make a “lifetime of liver health” a reality for patients. With discovery through research , collaboration and therapeutic implementation. Just great! vcuhealth.org/news/vcu-liver…

Delighted to join and appreciate all the well-wishers. Lots to do!

Quick life update - Successfully defended my PhD Thesis!!! Thank you to all members of Emory Genetics and Molecular Biology , my committee, and importantly, my PI Saul Karpen . My next chapter will begin in June Massachusetts Institute of Technology (MIT) in the Prof Linda Gay Griffith lab 🎉

Impactful week for the Stravitz-Sanyal Institute for Metabolic Health and Liver Disease VCU Stravitz-Sanyal Institute for Liver Disease : Major MASH clinical trial presentations at EASL by Dr. Arun Sanyal (with 2 NEJM publications). Important for hepatology and mostly for our patients.@arunjsanyalvcu,Rohit Loomba

Timely and important NYT article on MASLD with insights from @meenabbansal, Maru Rinella MD, and @arunjsanyalvcu. nytimes.com/2024/10/01/wel…

Spectacular group of engaged, creative and vibrant Young Investigators at the AASLD-EASL Masterclass. Great combination of spirit, energy, ideas with a commitment to make patients lives better through collaborative research!

#standupforscience2025 We improve our lives, and our patients lives, by continuing to believe in and support research. It is one of the pillars of a modern advanced society since The Enlightenment, especially when it involves NIH and allied institutions. Jewels in our crown.

Fabulous talk here at VCU from my friend and former co-fellow, the esteemed Dr. Peter Hotez. Peter had been a tireless champion of the power of vaccines to improve humanity, and his personal counter to the risks of anti-science rhetoric. Prof Peter Hotez MD PhD DSc(hon) Gonzalo Bearman VCU Stravitz-Sanyal Institute for Liver Disease

Really inspiring 1st SSI Research Retreat at the VCU James River venue. 70 engaged motivated participants to help move all our initiatives forward. Clinical. Translational. Basic. Global. Just fantastic. Lots to do! Arun J. Sanyal , Jasmohan Bajaj , Juan Pablo (JP) Arab, MD , VCU Stravitz-Sanyal Institute for Liver Disease.

The Cure Hepatitis C Act of 2025 represents a unique opportunity to cure a devastating virus while saving over $6 billion in the 10-year budget window. Learn more about the legislation. bit.ly/4ckbExT

.Arun J. Sanyal: This recognition of our high-quality GI-Hep program as one with tremendous academic research performance reflects the wide-ranging expertise of our dedicated faculty and staff, who make the science in our program possible. bit.ly/4nhaJFf #livertwitter